80 related articles for article (PubMed ID: 1201297)
21. Influence of NaCl on the kinetic behaviour of mammalian muscle acetylcholinesterase.
Perez-Guillermo F; Garcia-Carmona F; Garcia-Canovas F; Vidal CJ
Biochem Int; 1987 Mar; 14(3):385-94. PubMed ID: 3593383
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of the effect of verapamil and tubocurarine on acetylcholinesterase of skeletal muscle sarcolemma].
Diadiusha GP; Poliakova NK
Ukr Biokhim Zh (1978); 1983; 55(5):513-6. PubMed ID: 6636311
[TBL] [Abstract][Full Text] [Related]
23. Anthroylcholine bromide: a fluorescent ligand for the muscarinic receptor.
Ripoll C; Rubio E; Soria B
Gen Physiol Biophys; 1992 Jun; 11(3):241-9. PubMed ID: 1426974
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of membrane-bound acetylcholinesterase by d-tubocurarine and its reversal by bivalent cations.
Wins P; Schoffeniels E; Foidart JM
Life Sci; 1970 Mar; 9(5):259-67. PubMed ID: 5440030
[No Abstract] [Full Text] [Related]
25. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
[TBL] [Abstract][Full Text] [Related]
26. Molecular properties and inhibition kinetics of acetylcholinesterase obtained from rat brain and cockroach ganglion.
Singh AK
Toxicol Ind Health; 1990 Dec; 6(6):551-70. PubMed ID: 2097819
[TBL] [Abstract][Full Text] [Related]
27. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
28. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
[TBL] [Abstract][Full Text] [Related]
30. [Synthetic bioantioxidants--inhibitors of acetylcholinesterase activity].
Braginskaia FI; Zorina OM; Molochkina EM; Nikiforov GA; Burlakova EB
Izv Akad Nauk SSSR Biol; 1992; (5):690-8. PubMed ID: 1447418
[TBL] [Abstract][Full Text] [Related]
31. Methyl-paraoxon comparative inhibition kinetics for acetylcholinesterases from brain of neotropical fishes.
Silva Filho MV; Oliveira MM; Salles JB; Bastos VL; Cassano VP; Bastos JC
Toxicol Lett; 2004 Nov; 153(2):247-54. PubMed ID: 15451556
[TBL] [Abstract][Full Text] [Related]
32. Histochemical activity of some enzymes in the mesencephalon during ontogenic development of the rabbit and the guinea-pig. IV. The activity of acetylcholinesterase and monoamine oxidase as related with structural and functional differentiation.
Wawrzyniak M
Folia Histochem Cytochem (Krakow); 1966; 4(4):373-87. PubMed ID: 5959687
[No Abstract] [Full Text] [Related]
33. Acceleration of Drosophila melanogaster acetylcholinesterase methanesulfonylation: peripheral ligand D-tubocurarine enhances the affinity for small methanesulfonylfluoride.
Golicnik M; Fournier D; Stojan J
Chem Biol Interact; 2002 Feb; 139(2):145-57. PubMed ID: 11823003
[TBL] [Abstract][Full Text] [Related]
34. Activity of the soluble and membrane-bound acetylcholinesterase of the rabbit brain during development.
Niemierko S; Skangiel-Kramska J
Bull Acad Pol Sci Biol; 1976; 24(8):445-8. PubMed ID: 990967
[No Abstract] [Full Text] [Related]
35. [On the affinity of arecaidine derivatives for acetylcholinesterase of guinea pig erythrocytes].
König E; Lüllmann H; Mutschler E
Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):142-51. PubMed ID: 6030234
[No Abstract] [Full Text] [Related]
36. Kinetic characterization of acetylcholinesterase of muscle and rat brain.
Varela JM
Experientia; 1973 Nov; 29(11):1347-9. PubMed ID: 4761234
[No Abstract] [Full Text] [Related]
37. Monoclonal antibodies to rat brain acetylcholinesterase: comparative affinity for soluble and membrane-associated enzyme and for enzyme from different vertebrate species.
Rakonczay Z; Brimijoin S
J Neurochem; 1986 Jan; 46(1):280-7. PubMed ID: 3510009
[TBL] [Abstract][Full Text] [Related]
38. [Hill coefficient for the fluorine inactivation of solubilized and membrane-bound erythrocyte acetylcholinesterase in irradiated rats].
Fomenko BS; Dovgiĭ IE
Radiobiologiia; 1979; 19(4):591-3. PubMed ID: 504603
[No Abstract] [Full Text] [Related]
39. Puromycin as an inhibitor of rat brain acetylcholinesterase.
Moss DE; Moss DR; Fahrney D
Pharmacol Biochem Behav; 1974; 2(2):271-5. PubMed ID: 4829603
[No Abstract] [Full Text] [Related]
40. Functional consequences of ligand-dependent conformational changes in trypsin-solubilized and in membrane particle constrained-acetylcholinesterase.
Pattison S; Bernhard S
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3613-7. PubMed ID: 278976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
